Overview

Thymoglobulin in Cadaver Donor

Status:
Completed
Trial end date:
2012-02-01
Target enrollment:
0
Participant gender:
All
Summary
To determine the efficacy and Security of Thymoglobuline in cadaveric donor Efficacy: To demonstrate that in cadaveric donor, Thymoglobuline diminished graft alloreactivity by decreasing expression of inflammatory markers in graft biopsies Security:To demonstrate that the administration of Thymoglobulin does not have side effects in renal recipients.
Phase:
Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Instituto de Investigación Hospital Universitario La Paz
Collaborator:
Hospital de Santa Maria, Portugal
Treatments:
Thymoglobulin
Criteria
Inclusion Criteria:

- Accepted adults cadaveric donors for renal transplant from University Hospital La Paz(
Madrid) and from University Hospital Santa Maria (Lisbon)

- Informed consent from relatives for including in the study

Exclusion Criteria:

- Known allergy to the rabbit proteins

- Non accepted grafts

- Family refusal to consent